iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Up 19.3% in August

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 80,300 shares, an increase of 19.3% from the July 31st total of 67,300 shares. Based on an average daily volume of 28,500 shares, the days-to-cover ratio is presently 2.8 days. Currently, 0.9% of the company’s shares are sold short.

Hedge Funds Weigh In On iCoreConnect

An institutional investor recently bought a new position in iCoreConnect stock. Sapient Capital LLC acquired a new stake in iCoreConnect Inc. (NASDAQ:ICCT) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 31,256 shares of the company’s stock, valued at approximately $39,000. Sapient Capital LLC owned 0.35% of iCoreConnect at the end of the most recent reporting period. Institutional investors and hedge funds own 13.42% of the company’s stock.

iCoreConnect Stock Performance

ICCT stock opened at $0.51 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.11 and a quick ratio of 0.11. The stock has a 50-day moving average price of $0.69 and a two-hundred day moving average price of $1.02. iCoreConnect has a 12-month low of $0.46 and a 12-month high of $20.70.

iCoreConnect (NASDAQ:ICCT) last posted its quarterly earnings results on Friday, August 16th. The company reported ($1.10) EPS for the quarter. The company had revenue of $3.09 million for the quarter.

iCoreConnect Company Profile

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.